|
Zenith - Exempt Distribution
|
5
|
Zenith Epigenetics
|
Apr 01, 2022 10:46AM
|
|
Zrnith- Exempt Distribution
|
1
|
Zenith Epigenetics
|
Apr 01, 2022 09:58AM
|
|
RVX- Exempt Distribution
|
1
|
Resverlogix Corp.
|
Apr 01, 2022 09:51AM
|
|
Financial Reporting Dec 31, 2021 + MD&A now on SEDAR
|
5
|
Resverlogix Corp.
|
Apr 01, 2022 05:47AM
|
|
Re: Covid China
|
2
|
Resverlogix Corp.
|
Mar 30, 2022 02:48PM
|
|
Re: Covid China
|
3
|
Resverlogix Corp.
|
Mar 30, 2022 12:59PM
|
|
Re: Covid China
|
4
|
Resverlogix Corp.
|
Mar 30, 2022 11:52AM
|
|
Re: Covid China
|
2
|
Resverlogix Corp.
|
Mar 29, 2022 12:53PM
|
|
Re: Covid China
|
2
|
Resverlogix Corp.
|
Mar 29, 2022 10:21AM
|
|
Re: Covid China
|
3
|
Resverlogix Corp.
|
Mar 29, 2022 09:58AM
|
|
Re: Covid China
|
2
|
Resverlogix Corp.
|
Mar 29, 2022 06:52AM
|
|
Re: Drugmakers, scientists begin the hunt for long COVID treatments
|
3
|
Resverlogix Corp.
|
Mar 28, 2022 10:20AM
|
|
Re: Drugmakers, scientists begin the hunt for long COVID treatments
|
2
|
Resverlogix Corp.
|
Mar 28, 2022 08:48AM
|
|
Re: Drugmakers, scientists begin the hunt for long COVID treatments
|
2
|
Resverlogix Corp.
|
Mar 26, 2022 10:01AM
|
|
Re: what are the chances?
|
2
|
Resverlogix Corp.
|
Mar 24, 2022 07:54PM
|
|
Re: what are the chances?
|
1
|
Resverlogix Corp.
|
Mar 24, 2022 07:15PM
|
|
Re: Sachs conference with Bioasis
|
2
|
BIOASIS TECHNOLOGIES INC
|
Mar 24, 2022 07:04AM
|
|
Re: Apabetalone’s Positive Impact on Pulmonary Arterial Hypertension Published in the American Journal of Respiratory and Critical Care Medicine
|
3
|
Resverlogix Corp.
|
Mar 18, 2022 12:41PM
|
|
Re: Apabetalone’s Positive Impact on Pulmonary Arterial Hypertension Published in the American Journal of Respiratory and Critical Care Medicine
|
5
|
Resverlogix Corp.
|
Mar 18, 2022 10:33AM
|
|
Re: So I was able to finally set up a one on one meeting with...
|
2
|
Resverlogix Corp.
|
Mar 16, 2022 08:29AM
|
